Establishment Labs Holdings Inc. (NASDAQ:ESTA) Stock Holdings Increased by Boothbay Fund Management LLC

Boothbay Fund Management LLC grew its holdings in shares of Establishment Labs Holdings Inc. (NASDAQ:ESTA - Free Report) by 68.8% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 525,248 shares of the company's stock after buying an additional 214,119 shares during the quarter. Establishment Labs accounts for 0.6% of Boothbay Fund Management LLC's portfolio, making the stock its 17th largest position. Boothbay Fund Management LLC owned about 1.88% of Establishment Labs worth $24,198,000 as of its most recent SEC filing.

Several other large investors also recently made changes to their positions in ESTA. R Squared Ltd acquired a new stake in Establishment Labs during the 4th quarter valued at $36,000. Federated Hermes Inc. grew its stake in shares of Establishment Labs by 3.0% during the fourth quarter. Federated Hermes Inc. now owns 32,720 shares of the company's stock valued at $1,507,000 after acquiring an additional 953 shares in the last quarter. Swiss National Bank increased its position in shares of Establishment Labs by 2.7% during the fourth quarter. Swiss National Bank now owns 38,500 shares of the company's stock worth $1,774,000 after acquiring an additional 1,000 shares during the last quarter. Handelsbanken Fonder AB lifted its stake in shares of Establishment Labs by 32.3% in the fourth quarter. Handelsbanken Fonder AB now owns 8,200 shares of the company's stock worth $378,000 after acquiring an additional 2,000 shares in the last quarter. Finally, SkyView Investment Advisors LLC increased its stake in shares of Establishment Labs by 30.5% in the third quarter. SkyView Investment Advisors LLC now owns 12,000 shares of the company's stock worth $519,000 after buying an additional 2,805 shares during the last quarter. Institutional investors and hedge funds own 72.91% of the company's stock.

Establishment Labs Stock Performance

ESTA stock traded up $0.09 on Wednesday, reaching $30.35. The company's stock had a trading volume of 214,116 shares, compared to its average volume of 206,159. Establishment Labs Holdings Inc. has a 52 week low of $28.89 and a 52 week high of $31.00. The company has a debt-to-equity ratio of 5.94, a current ratio of 3.62 and a quick ratio of 2.29. The company has a market capitalization of $875.48 million, a P/E ratio of -11.76 and a beta of 0.77. The firm has a fifty day moving average of $35.86 and a two-hundred day moving average of $39.08.

Establishment Labs (NASDAQ:ESTA - Get Free Report) last issued its quarterly earnings results on Wednesday, February 26th. The company reported ($0.98) EPS for the quarter, missing analysts' consensus estimates of ($0.64) by ($0.34). The business had revenue of $44.51 million for the quarter, compared to analyst estimates of $44.45 million. Establishment Labs had a negative net margin of 46.13% and a negative return on equity of 184.55%. As a group, analysts predict that Establishment Labs Holdings Inc. will post -2.41 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of research analysts have commented on ESTA shares. Stephens reaffirmed an "overweight" rating and set a $52.00 target price on shares of Establishment Labs in a report on Thursday, March 6th. Needham & Company LLC started coverage on shares of Establishment Labs in a report on Monday, April 14th. They issued a "hold" rating on the stock. Two investment analysts have rated the stock with a hold rating and four have issued a buy rating to the company's stock. According to MarketBeat, the company currently has a consensus rating of "Moderate Buy" and a consensus target price of $57.40.

About Establishment Labs

Establishment Labs Holdings Inc, a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander.